Author

Ziju Elanjikal

Observed names: Z. Elanjikal, ZIJU ELANJIKAL

Institution: University Hospitals Bristol and Weston NHS Foundation Trust

Observed institutions: Goethe University Frankfurt, Robert Koch Institute, University Hospitals Bristol NHS Foundation Trust, Sankt Gertrauden Krankenhaus, St Michael's Hospital, Georg Speyer Haus, University Hospitals Bristol and Weston NHS Foundation Trust

OpenAlex ID: A5054757477

Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis

2003 · ZIJU ELANJIKAL, JAN SÖRENSEN, et al. · The Pediatric Infectious Disease Journal · 32

Human Immunodeficiency Virus (HIV)-Positive Sera Obtained Shortly after Seroconversion Neutralize Autologous HIV Type 1 Isolates on Primary Macrophages but Not on Lymphocytes

2000 · Horst Ruppach, Peter Nara, et al. · Journal of Virology · 32

Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn

2025 · Derek P. de Winter, E. J. T. (Joanne) Verweij, et al. · JAMA Network Open · 18

Modified Seldinger technique for neonatal epicutaneo-caval catheter insertion: A non-randomised retrospective study

2021 · Jack JC Gibb, Rachael MacLeod, et al. · The Journal of Vascular Access · 10

55 Modified seldinger technique for neonatal peripherally inserted central catheter placement

2021 · Rachael MacLeod, Jack Gibb, et al. · Abstracts · 5

2003 · ZIJU ELANJIKAL, JAN SORENSEN, et al. · The Pediatric Infectious Disease Journal · 2

Administration of Recombinant Factor FVIIa (NovoSeven, NovoNordisk) in a Patient with Glanzmann Thrombasthenia

2005 · A. Zyschka, Z. Elanjikal, et al. · Springer eBooks

Works count: 8

Citation count: 99

H-index: 5

I10-index: 4